We Really Need Clear Guidelines and Recommendations for Safer and Proper Use of Aripiprazole and Risperidone in a Pediatric Population: Real-World Analysis of EudraVigilance Database
Conclusions: Our results demonstrate that spontaneously reported adverse events associated with aripiprazole and risperidone reflect what is already known in terms of safety profile, although with about 90% of them being serious. This analysis stresses the need for further studies and effective training and information activities to better define the actual benefit/risk ratio of these drugs in pediatric patients.
Source: Frontiers in Psychiatry - Category: Psychiatry Source Type: research
More News: Abilify | ADHD | Autism | Bipolar | Children | Databases & Libraries | Depression | Drugs & Pharmacology | Gynecomastia | Hyperactivity | Mania | Nutrition | Pediatrics | Psychiatry | Risperdal Consta | Schizophrenia | Study | Suicide | Training | Universities & Medical Training